Saving orphan drug legislations: misconceptions and clarifications

Expert Review of Pharmacoeconomics & Outcomes Research
H I HyryJ C P Roos

Abstract

Orphan-drug sales are rocketing, with revenue expected to total $176 billion annually by 2020. As a share of the industry, orphan drugs now account for close to 15% of all prescription revenue globally (excluding generics) and the sector is set to grow at more than twice the rate (10.5%) of the overall prescription market (4.3%). But this success also equates to costs--borne by individual patients and cash-strapped health systems. Prices for orphan drugs can be 19 times higher than for other medications, hampering access for patients, many of whom are children. With ever more such expensive drugs reaching the market, the situation is becoming unsustainable and putting the survival of the orphan drug legislation itself at risk. Here the authors consider why there has been an increase in orphan drug designations, how orphan drug prices are set and regulated, before discussing proposals for how changes which could save the legislation.

References

Jan 20, 2007·International Journal of Technology Assessment in Health Care·Michael F DrummondJoan Rovira
Oct 19, 2007·The New England Journal of Medicine·Alan M Garber, Mark B McClellan
Nov 18, 2010·BMJ : British Medical Journal·Jonathan C P RoosTimothy M Cox
Mar 8, 2011·Drug Discovery Today·Sean EkinsJoel S Freundlich
Mar 1, 2012·PloS One·Aaron S KesselheimJerry Avorn
Aug 15, 2012·BMJ : British Medical Journal·Tony Sheldon
Jan 24, 2014·QJM : Monthly Journal of the Association of Physicians·H I HyryJ C P Roos
Jun 5, 2015·Nature·Heidi Ledford
Aug 22, 2015·Orphanet Journal of Rare Diseases·Hanna I HyryJonathan C P Roos
Nov 19, 2015·The New England Journal of Medicine·Peter J Neumann, Joshua T Cohen

❮ Previous
Next ❯

Citations

Apr 16, 2020·British Journal of Clinical Pharmacology·Robert Likic
Jan 22, 2020·BMJ : British Medical Journal·Rosalind L Smyth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the Indiana State Medical Association
V E Tyler
British Journal of Addiction
P Bucknell
Clinical Advances in Hematology & Oncology : H&O
Deborah Schrag
© 2022 Meta ULC. All rights reserved